Phosphoproteomics Provides Novel Insights into the Response of Primary Acute Lymphoblastic Leukemia Cells to Microtubule Depolymerization in G1 Phase of the Cell Cycle-Reference-Cited by-同舟云学术

Phosphoproteomics Provides Novel Insights into the Response of Primary Acute Lymphoblastic Leukemia Cells to Microtubule Depolymerization in G1 Phase of the Cell Cycle

Published:2021-09-16 Issue:38 Volume:6 Page:24949-24959
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Delgado Magdalena¹,Washam Charity L.¹²,Urbaniak Alicja¹,Heflin Billie¹,Storey Aaron J.¹,Lan Renny S.¹,Mackintosh Samuel G.¹,Tackett Alan J.¹²³^ORCID,Byrum Stephanie D.¹²³^ORCID,Chambers Timothy C.¹³^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, United States

2. Arkansas Children’s Research Institute, 13 Children’s Way, Little Rock, Arkansas 72202, United States

3. Winthrop P. Rockefeller Cancer Institute, 449 Jack Stephens Dr, Little Rock, Arkansas 72205, United States

Funder

National Institute of General Medical Sciences

Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.1c03936

Reference63 articles.

1. Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton

2. Microtubule-binding agents: a dynamic field of cancer therapeutics

3. Rowinsky, E. K.; Donehower, R. C. The Chemotherapy Source Book; Williams and Wilkins: Baltimore, MD, 1998; pp 387–423.

4. Microtubule destabilising agents: far more than just antimitotic anticancer drugs

5. Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead